$XNOM.OB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Cardiff Oncology, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Cardiff Oncology, Inc.. Get notifications about new insider transactions in Cardiff Oncology, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 15 2021 | XNOM.OB | Cardiff Oncology, ... | JACOB GARY S | Option Exercise | J | 2.48 | 44,734 | 110,940 | 76,106 | ||
Jun 15 2021 | XNOM.OB | Cardiff Oncology, ... | JACOB GARY S | Option Exercise | J | 21.60 | 755 | 16,308 | 76,106 | ||
Jun 15 2021 | XNOM.OB | Cardiff Oncology, ... | JACOB GARY S | Option Exercise | J | 51.84 | 530 | 27,475 | 76,106 | ||
Jun 15 2021 | XNOM.OB | Cardiff Oncology, ... | JACOB GARY S | Option Exercise | J | 372.96 | 223 | 83,170 | 76,106 | ||
Jun 15 2021 | XNOM.OB | Cardiff Oncology, ... | JACOB GARY S | Option Exercise | J | 516.96 | 223 | 115,282 | 76,106 | ||
Jun 15 2021 | XNOM.OB | Cardiff Oncology, ... | JACOB GARY S | Option Exercise | J | 316.08 | 218 | 68,905 | 76,106 | ||
Jun 15 2021 | XNOM.OB | Cardiff Oncology, ... | JACOB GARY S | Option Exercise | J | 447.84 | 293 | 131,217 | 76,106 | ||
Jun 15 2021 | XNOM.OB | Cardiff Oncology, ... | JACOB GARY S | Option Exercise | J | 2.60 | 28,858 | 75,031 | 76,106 | ||
Mar 29 2021 | XNOM.OB | Cardiff Oncology, ... | Markin Rodney S | Director | Buy | P | 10.32 | 2,900 | 29,933 | 23,879 | 21 K to 23.9 K (+13.82 %) |
Mar 24 2021 | XNOM.OB | Cardiff Oncology, ... | PACE GARY W | Director | Buy | P | 10.31 | 2,500 | 25,775 | 464,811 | 462.3 K to 464.8 K (+0.54 %) |
Mar 24 2021 | XNOM.OB | Cardiff Oncology, ... | PACE GARY W | Director | Buy | P | 10.21 | 2,500 | 25,525 | 462,311 | 459.8 K to 462.3 K (+0.54 %) |
Mar 24 2021 | XNOM.OB | Cardiff Oncology, ... | PACE GARY W | Director | Buy | P | 10.20 | 5,000 | 51,000 | 459,811 | 454.8 K to 459.8 K (+1.10 %) |
Mar 23 2021 | XNOM.OB | Cardiff Oncology, ... | JACOB GARY S | Director | Buy | P | 10.40 | 470 | 4,886 | 21,922 | 21.5 K to 21.9 K (+2.19 %) |
Mar 23 2021 | XNOM.OB | Cardiff Oncology, ... | JACOB GARY S | Director | Buy | P | 10.42 | 1,900 | 19,804 | 21,452 | 19.6 K to 21.5 K (+9.72 %) |
Mar 23 2021 | XNOM.OB | Cardiff Oncology, ... | Kelemen Vicki | Exec. VP and COO | Buy | P | 10.31 | 960 | 9,898 | 6,053 | 5.1 K to 6.1 K (+18.85 %) |
Mar 23 2021 | XNOM.OB | Cardiff Oncology, ... | Erlander Mark | Chief Executive Off ... | Buy | P | 10.34 | 965 | 9,980 | 14,481 | 13.5 K to 14.5 K (+7.14 %) |
Mar 22 2021 | XNOM.OB | Cardiff Oncology, ... | BRANCACCIO JOHN P | Director | Buy | P | 10.95 | 3,000 | 32,850 | 12,260 | 9.3 K to 12.3 K (+32.40 %) |
Mar 19 2021 | XNOM.OB | Cardiff Oncology, ... | PACE GARY W | Director | Buy | P | 10.54 | 2,000 | 21,080 | 454,811 | 452.8 K to 454.8 K (+0.44 %) |
Mar 19 2021 | XNOM.OB | Cardiff Oncology, ... | PACE GARY W | Director | Buy | P | 10.54 | 2,000 | 21,080 | 454,811 | 452.8 K to 454.8 K (+0.44 %) |
Mar 19 2021 | XNOM.OB | Cardiff Oncology, ... | PACE GARY W | Director | Buy | P | 10.58 | 1,000 | 10,580 | 452,811 | 451.8 K to 452.8 K (+0.22 %) |
Mar 19 2021 | XNOM.OB | Cardiff Oncology, ... | PACE GARY W | Director | Buy | P | 10.58 | 1,000 | 10,580 | 452,811 | 451.8 K to 452.8 K (+0.22 %) |
Mar 04 2021 | XNOM.OB | Cardiff Oncology, ... | PACE GARY W | Director | Buy | P | 9.27 | 1,500 | 13,898 | 451,811 | 450.3 K to 451.8 K (+0.33 %) |
Jan 05 2021 | XNOM.OB | Cardiff Oncology, ... | Kelemen Vicki | Exec. VP and COO | Option Exercise | M | 0.00 | 70 | 0 | 0 | |
Jan 05 2021 | XNOM.OB | Cardiff Oncology, ... | Kelemen Vicki | Exec. VP and COO | Payment of Exercise | F | 0.00 | 31 | 0 | 5,093 | 5.1 K to 5.1 K (-0.60 %) |
Jan 05 2021 | XNOM.OB | Cardiff Oncology, ... | Kelemen Vicki | Exec. VP and COO | Buy | M | 0.00 | 70 | 0 | 5,124 | 5.1 K to 5.1 K (+1.39 %) |
Jan 05 2021 | XNOM.OB | Cardiff Oncology, ... | Erlander Mark | Chief Executive Off ... | Option Exercise | M | 0.00 | 260 | 0 | 0 | |
Jan 05 2021 | XNOM.OB | Cardiff Oncology, ... | Erlander Mark | Chief Executive Off ... | Payment of Exercise | F | 0.00 | 113 | 0 | 13,516 | 13.6 K to 13.5 K (-0.83 %) |
Jan 05 2021 | XNOM.OB | Cardiff Oncology, ... | Erlander Mark | Chief Executive Off ... | Buy | M | 0.00 | 260 | 0 | 13,629 | 13.4 K to 13.6 K (+1.94 %) |
Nov 25 2020 | XNOM.OB | Cardiff Oncology, ... | Kelemen Vicki | Exec. VP and COO | Option Exercise | M | 2.48 | 35,321 | 87,596 | 70,641 | |
Nov 25 2020 | XNOM.OB | Cardiff Oncology, ... | Kelemen Vicki | Exec. VP and COO | Sell | S | 18.60 | 35,321 | 657,020 | 5,054 | 40.4 K to 5.1 K (-87.48 %) |
Nov 25 2020 | XNOM.OB | Cardiff Oncology, ... | Kelemen Vicki | Exec. VP and COO | Buy | M | 2.48 | 35,321 | 87,596 | 40,375 | 5.1 K to 40.4 K (+698.87 %) |
Sep 17 2020 | XNOM.OB | Cardiff Oncology, ... | PACE GARY W | Director | Buy | P | 5.71 | 850 | 4,854 | 450,311 | 449.5 K to 450.3 K (+0.19 %) |
Sep 17 2020 | XNOM.OB | Cardiff Oncology, ... | PACE GARY W | Director | Buy | P | 5.69 | 1,700 | 9,673 | 449,461 | 447.8 K to 449.5 K (+0.38 %) |
Jun 19 2020 | XNOM.OB | Cardiff Oncology, ... | PACE GARY W | Director | Option Exercise | A | 2.60 | 28,858 | 75,031 | 40,774 | |
Jun 19 2020 | XNOM.OB | Cardiff Oncology, ... | Armitage James O | Director | Option Exercise | A | 2.60 | 28,858 | 75,031 | 40,774 | |
Jun 19 2020 | XNOM.OB | Cardiff Oncology, ... | White Lale | Director | Option Exercise | A | 2.60 | 28,858 | 75,031 | 40,774 | |
Jun 19 2020 | XNOM.OB | Cardiff Oncology, ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 2.60 | 28,858 | 75,031 | 76,517 | |
Jun 19 2020 | XNOM.OB | Cardiff Oncology, ... | JACOB GARY S | Director | Option Exercise | A | 2.60 | 28,858 | 75,031 | 76,106 | |
May 18 2020 | XNOM.OB | Cardiff Oncology, ... | Erlander Mark | Chief Executive Off ... | Buy | P | 1.43 | 6,993 | 10,000 | 13,369 | 6.4 K to 13.4 K (+109.68 %) |
May 18 2020 | XNOM.OB | Cardiff Oncology, ... | Markin Rodney S | Director | Buy | P | 1.43 | 20,979 | 30,000 | 28,160 | 7.2 K to 28.2 K (+292.15 %) |
May 18 2020 | XNOM.OB | Cardiff Oncology, ... | BRANCACCIO JOHN P | Director | Buy | P | 1.43 | 6,993 | 10,000 | 9,260 | 2.3 K to 9.3 K (+308.47 %) |
May 18 2020 | XNOM.OB | Cardiff Oncology, ... | JACOB GARY S | Director | Buy | P | 1.43 | 17,483 | 25,001 | 19,552 | 2.1 K to 19.6 K (+845.00 %) |
May 18 2020 | XNOM.OB | Cardiff Oncology, ... | White Lale | Director | Buy | P | 1.43 | 69,930 | 100,000 | 69,930 | 0 to 69.9 K |
May 13 2020 | XNOM.OB | Cardiff Oncology, ... | PACE GARY W | Director | Buy | P | 1.34 | 447,761 | 600,000 | 447,761 | 0 to 447.8 K |
May 01 2020 | XNOM.OB | Trovagene, Inc. | PACE GARY W | Director | Option Exercise | A | 0.98 | 11,916 | 11,678 | 11,916 | |
May 01 2020 | XNOM.OB | Trovagene, Inc. | Armitage James O | Director | Option Exercise | A | 0.98 | 11,916 | 11,678 | 11,916 | |
May 01 2020 | XNOM.OB | Trovagene, Inc. | White Lale | Director | Option Exercise | A | 0.98 | 11,916 | 11,678 | 11,916 | |
Oct 03 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | M | 0.00 | 1,250 | 0 | 1,771 | |
Oct 03 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Payment of Exercise | F | 0.00 | 466 | 0 | 5,533 | 6 K to 5.5 K (-7.77 %) |
Oct 03 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Buy | M | 0.00 | 1,250 | 0 | 5,999 | 4.7 K to 6 K (+26.32 %) |
Jul 03 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | M | 0.00 | 1,250 | 0 | 3,021 | |
Jul 03 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Payment of Exercise | F | 0.00 | 461 | 0 | 4,749 | 5.2 K to 4.7 K (-8.85 %) |
Jul 03 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Buy | M | 0.00 | 1,250 | 0 | 5,210 | 4 K to 5.2 K (+31.57 %) |
Jun 24 2019 | XNOM.OB | Trovagene, Inc. | JACOB GARY S | Director | Option Exercise | A | 2.48 | 44,734 | 110,940 | 48,071 | |
Jun 24 2019 | XNOM.OB | Trovagene, Inc. | ADAMS THOMAS PHD | Chief Executive Off ... | Option Exercise | A | 2.48 | 298,230 | 739,610 | 304,725 | |
Jun 24 2019 | XNOM.OB | Trovagene, Inc. | Markin Rodney S | Director | Option Exercise | A | 2.48 | 44,734 | 110,940 | 46,969 | |
Jun 24 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | A | 2.48 | 134,203 | 332,823 | 158,959 | |
Jun 24 2019 | XNOM.OB | Trovagene, Inc. | Countouriotis Athena | Director | Option Exercise | A | 2.48 | 44,734 | 110,940 | 46,019 | |
Jun 24 2019 | XNOM.OB | Trovagene, Inc. | BRANCACCIO JOHN P | Director | Option Exercise | A | 2.48 | 44,734 | 110,940 | 47,806 | |
Apr 03 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | M | 0.00 | 1,250 | 0 | 4,271 | |
Apr 03 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Payment of Exercise | F | 0.00 | 459 | 0 | 3,960 | 4.4 K to 4 K (-10.39 %) |
Apr 03 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Buy | M | 0.00 | 1,250 | 0 | 4,419 | 3.2 K to 4.4 K (+39.44 %) |
Jan 04 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | M | 0.00 | 1,563 | 0 | 33,125 | |
Jan 04 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Payment of Exercise | F | 0.00 | 698 | 0 | 19,010 | 19.7 K to 19 K (-3.54 %) |
Jan 04 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Buy | M | 0.00 | 1,563 | 0 | 19,708 | 18.1 K to 19.7 K (+8.61 %) |
Jan 04 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | M | 0.00 | 7,500 | 0 | 34,688 | |
Jan 04 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Payment of Exercise | F | 0.00 | 3,035 | 0 | 18,145 | 21.2 K to 18.1 K (-14.33 %) |
Jan 04 2019 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Buy | M | 0.00 | 7,500 | 0 | 21,180 | 13.7 K to 21.2 K (+54.82 %) |
Oct 03 2018 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | M | 0.00 | 7,500 | 0 | 42,188 | |
Oct 03 2018 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Payment of Exercise | F | 0.00 | 2,731 | 0 | 13,680 | 16.4 K to 13.7 K (-16.64 %) |
Oct 03 2018 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Buy | M | 0.00 | 7,500 | 0 | 16,411 | 8.9 K to 16.4 K (+84.17 %) |
Jul 26 2018 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | A | 0.00 | 45,000 | 0 | 49,688 | |
Jun 21 2018 | XNOM.OB | Trovagene, Inc. | Markin Rodney S | Director | Buy | P | 0.85 | 41,200 | 35,020 | 63,810 | 22.6 K to 63.8 K (+182.22 %) |
Jun 11 2018 | XNOM.OB | Trovagene, Inc. | BRANCACCIO JOHN P | Director | Buy | P | 0.80 | 10,000 | 8,000 | 53,167 | 43.2 K to 53.2 K (+23.17 %) |
Jun 11 2018 | XNOM.OB | Trovagene, Inc. | Tennant Stanley | Director | Buy | P | 0.80 | 10,000 | 8,000 | 236,061 | 226.1 K to 236.1 K (+4.42 %) |
Feb 01 2018 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | M | 0.00 | 90,000 | 0 | 56,250 | |
Feb 01 2018 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Payment of Exercise | F | 0.00 | 42,930 | 0 | 104,367 | 147.3 K to 104.4 K (-29.15 %) |
Feb 01 2018 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Buy | M | 0.00 | 90,000 | 0 | 147,297 | 57.3 K to 147.3 K (+157.08 %) |
Feb 01 2018 | XNOM.OB | Trovagene, Inc. | WELCH WILLIAM J | Chief Executive Off ... | Option Exercise | M | 0.00 | 130,000 | 0 | 150,000 | |
Feb 01 2018 | XNOM.OB | Trovagene, Inc. | WELCH WILLIAM J | Chief Executive Off ... | Payment of Exercise | F | 0.00 | 62,010 | 0 | 842,645 | 904.7 K to 842.6 K (-6.85 %) |
Feb 01 2018 | XNOM.OB | Trovagene, Inc. | WELCH WILLIAM J | Chief Executive Off ... | Buy | M | 0.00 | 130,000 | 0 | 904,655 | 774.7 K to 904.7 K (+16.78 %) |
Jan 25 2018 | XNOM.OB | Trovagene, Inc. | BRANCACCIO JOHN P | Director | Option Exercise | A | 0.30 | 54,322 | 16,297 | 246,130 | |
Jan 25 2018 | XNOM.OB | Trovagene, Inc. | Billings Paul | Director | Option Exercise | A | 0.30 | 54,322 | 16,297 | 175,658 | |
Jan 25 2018 | XNOM.OB | Trovagene, Inc. | Markin Rodney S | Director | Option Exercise | A | 0.30 | 54,322 | 16,297 | 160,658 | |
Jan 25 2018 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | A | 0.30 | 672,189 | 201,657 | 1,782,189 | |
Jan 25 2018 | XNOM.OB | Trovagene, Inc. | WELCH WILLIAM J | Chief Executive Off ... | Option Exercise | A | 0.30 | 662,500 | 198,750 | 1,412,500 | |
Jan 25 2018 | XNOM.OB | Trovagene, Inc. | Countouriotis Athena | Director | Option Exercise | A | 0.30 | 54,322 | 16,297 | 92,428 | |
Jan 25 2018 | XNOM.OB | Trovagene, Inc. | ADAMS THOMAS PHD | Director | Option Exercise | A | 0.30 | 54,322 | 16,297 | 467,277 | |
Jan 25 2018 | XNOM.OB | Trovagene, Inc. | JACOB GARY S | Director | Option Exercise | A | 0.30 | 54,322 | 16,297 | 248,101 | |
Jan 25 2018 | XNOM.OB | Trovagene, Inc. | Tennant Stanley | Director | Option Exercise | A | 0.30 | 54,322 | 16,297 | 185,586 | |
Jan 04 2018 | XNOM.OB | Trovagene, Inc. | BRANCACCIO JOHN P | Director | Option Exercise | M | 0.00 | 16,667 | 0 | 0 | |
Jan 04 2018 | XNOM.OB | Trovagene, Inc. | BRANCACCIO JOHN P | Director | Buy | M | 0.00 | 16,667 | 0 | 43,167 | 26.5 K to 43.2 K (+62.89 %) |
Jan 04 2018 | XNOM.OB | Trovagene, Inc. | Tennant Stanley | Director | Option Exercise | M | 0.00 | 16,667 | 0 | 0 | |
Jan 04 2018 | XNOM.OB | Trovagene, Inc. | Tennant Stanley | Director | Buy | M | 0.00 | 16,667 | 0 | 234,545 | 217.9 K to 234.5 K (+7.65 %) |
Jan 04 2018 | XNOM.OB | Trovagene, Inc. | WELCH WILLIAM J | Chief Executive Off ... | Option Exercise | M | 0.00 | 50,000 | 0 | 280,000 | |
Jan 04 2018 | XNOM.OB | Trovagene, Inc. | WELCH WILLIAM J | Chief Executive Off ... | Payment of Exercise | F | 0.00 | 25,487 | 0 | 769,905 | 795.4 K to 769.9 K (-3.20 %) |
Jan 04 2018 | XNOM.OB | Trovagene, Inc. | WELCH WILLIAM J | Chief Executive Off ... | Buy | M | 0.00 | 50,000 | 0 | 795,392 | 745.4 K to 795.4 K (+6.71 %) |
Jan 04 2018 | XNOM.OB | Trovagene, Inc. | Billings Paul | Director | Option Exercise | M | 0.00 | 16,667 | 0 | 0 | |
Jan 04 2018 | XNOM.OB | Trovagene, Inc. | Billings Paul | Director | Buy | M | 0.00 | 16,667 | 0 | 16,667 | 0 to 16.7 K |
Jan 04 2018 | XNOM.OB | Trovagene, Inc. | ADAMS THOMAS PHD | Director | Option Exercise | M | 0.00 | 16,667 | 0 | 0 | |
Jan 04 2018 | XNOM.OB | Trovagene, Inc. | ADAMS THOMAS PHD | Director | Buy | M | 0.00 | 16,667 | 0 | 351,959 | 335.3 K to 352 K (+4.97 %) |
Jan 04 2018 | XNOM.OB | Trovagene, Inc. | JACOB GARY S | Director | Option Exercise | M | 0.00 | 16,667 | 0 | 0 | |
Jan 04 2018 | XNOM.OB | Trovagene, Inc. | JACOB GARY S | Director | Buy | M | 0.00 | 16,667 | 0 | 148,954 | 132.3 K to 149 K (+12.60 %) |
Jan 04 2018 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | M | 0.00 | 18,750 | 0 | 146,250 | |
Jan 04 2018 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Payment of Exercise | F | 0.00 | 9,558 | 0 | 57,243 | 66.8 K to 57.2 K (-14.31 %) |
Jan 04 2018 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Buy | M | 0.00 | 18,750 | 0 | 66,801 | 48.1 K to 66.8 K (+39.02 %) |
Jan 04 2018 | XNOM.OB | Trovagene, Inc. | Markin Rodney S | Director | Option Exercise | M | 0.00 | 16,667 | 0 | 0 | |
Jan 04 2018 | XNOM.OB | Trovagene, Inc. | Markin Rodney S | Director | Buy | M | 0.00 | 16,667 | 0 | 22,610 | 5.9 K to 22.6 K (+280.45 %) |
Oct 05 2017 | XNOM.OB | Trovagene, Inc. | Tennant Stanley | Director | Option Exercise | A | 0.72 | 38,106 | 27,436 | 131,264 | |
Oct 05 2017 | XNOM.OB | Trovagene, Inc. | Markin Rodney S | Director | Option Exercise | A | 0.72 | 38,106 | 27,436 | 106,336 | |
Oct 05 2017 | XNOM.OB | Trovagene, Inc. | JACOB GARY S | Director | Option Exercise | A | 0.72 | 38,106 | 27,436 | 193,779 | |
Oct 05 2017 | XNOM.OB | Trovagene, Inc. | BRANCACCIO JOHN P | Director | Option Exercise | A | 0.72 | 38,106 | 27,436 | 191,808 | |
Oct 05 2017 | XNOM.OB | Trovagene, Inc. | ADAMS THOMAS PHD | Director | Option Exercise | A | 0.72 | 38,106 | 27,436 | 412,955 | |
Sep 06 2017 | XNOM.OB | Trovagene, Inc. | JACOB GARY S | Director | Option Exercise | M | 0.00 | 9,287 | 0 | 16,667 | |
Sep 06 2017 | XNOM.OB | Trovagene, Inc. | JACOB GARY S | Director | Buy | M | 0.00 | 9,287 | 0 | 132,287 | 123 K to 132.3 K (+7.55 %) |
Sep 06 2017 | XNOM.OB | Trovagene, Inc. | Tennant Stanley | Director | Option Exercise | M | 0.00 | 8,484 | 0 | 16,667 | |
Sep 06 2017 | XNOM.OB | Trovagene, Inc. | Tennant Stanley | Director | Buy | M | 0.00 | 8,484 | 0 | 217,878 | 209.4 K to 217.9 K (+4.05 %) |
Sep 06 2017 | XNOM.OB | Trovagene, Inc. | Billings Paul | Director | Option Exercise | M | 0.00 | 6,498 | 0 | 16,667 | |
Sep 06 2017 | XNOM.OB | Trovagene, Inc. | Billings Paul | Director | Buy | M | 0.00 | 6,498 | 0 | 6,498 | 0 to 6.5 K |
Sep 06 2017 | XNOM.OB | Trovagene, Inc. | ADAMS THOMAS PHD | Director | Option Exercise | M | 0.00 | 8,806 | 0 | 16,667 | |
Sep 06 2017 | XNOM.OB | Trovagene, Inc. | ADAMS THOMAS PHD | Director | Buy | M | 0.00 | 8,806 | 0 | 335,292 | 326.5 K to 335.3 K (+2.70 %) |
Sep 06 2017 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | M | 0.00 | 30,001 | 0 | 165,000 | |
Sep 06 2017 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Payment of Exercise | F | 0.00 | 12,928 | 0 | 48,051 | 61 K to 48.1 K (-21.20 %) |
Sep 06 2017 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Buy | M | 0.00 | 30,001 | 0 | 61,033 | 31 K to 61 K (+96.68 %) |
Sep 06 2017 | XNOM.OB | Trovagene, Inc. | BRANCACCIO JOHN P | Director | Option Exercise | M | 0.00 | 12,667 | 0 | 16,667 | |
Sep 06 2017 | XNOM.OB | Trovagene, Inc. | BRANCACCIO JOHN P | Director | Buy | M | 0.00 | 12,667 | 0 | 26,500 | 13.8 K to 26.5 K (+91.57 %) |
Sep 06 2017 | XNOM.OB | Trovagene, Inc. | Markin Rodney S | Director | Option Exercise | M | 0.00 | 5,943 | 0 | 16,667 | |
Sep 06 2017 | XNOM.OB | Trovagene, Inc. | Markin Rodney S | Director | Buy | M | 0.00 | 5,943 | 0 | 5,943 | 0 to 5.9 K |
Sep 06 2017 | XNOM.OB | Trovagene, Inc. | Tennant Stanley | Director | Sell | S | 0.69 | 8,334 | 5,750 | 209,394 | 217.7 K to 209.4 K (-3.83 %) |
Aug 24 2017 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | A | 0.85 | 385,000 | 327,250 | 1,110,000 | |
Aug 17 2017 | XNOM.OB | Trovagene, Inc. | WELCH WILLIAM J | CEO | Grant | A | 0.00 | 745,392 | 0 | 745,392 | 0 to 745.4 K |
Apr 10 2017 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | A | 0.00 | 90,000 | 0 | 195,001 | |
Apr 10 2017 | XNOM.OB | Trovagene, Inc. | WELCH WILLIAM J | CEO | Option Exercise | A | 0.00 | 130,000 | 0 | 330,000 | |
Jan 04 2017 | XNOM.OB | Trovagene, Inc. | Tennant Stanley | Director | Option Exercise | A | 0.00 | 16,667 | 0 | 16,667 | |
Jan 04 2017 | XNOM.OB | Trovagene, Inc. | WELCH WILLIAM J | CEO | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
Jan 04 2017 | XNOM.OB | Trovagene, Inc. | ADAMS THOMAS PHD | Director | Option Exercise | A | 0.00 | 16,667 | 0 | 16,667 | |
Jan 04 2017 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | A | 0.00 | 75,000 | 0 | 105,001 | |
Jan 04 2017 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | A | 0.00 | 30,001 | 0 | 30,001 | |
Jan 04 2017 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Option Exercise | M | 0.00 | 50,000 | 0 | 0 | |
Jan 04 2017 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Payment of Exercise | F | 0.00 | 23,968 | 0 | 31,032 | 55 K to 31 K (-43.58 %) |
Jan 04 2017 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Buy | M | 0.00 | 50,000 | 0 | 55,000 | 5 K to 55 K (+1,000.00 %) |
Jan 04 2017 | XNOM.OB | Trovagene, Inc. | Billings Paul | Director | Option Exercise | A | 0.00 | 16,667 | 0 | 16,667 | |
Jan 04 2017 | XNOM.OB | Trovagene, Inc. | JACOB GARY S | Director | Option Exercise | A | 0.00 | 16,667 | 0 | 16,667 | |
Jan 04 2017 | XNOM.OB | Trovagene, Inc. | BRANCACCIO JOHN P | Director | Option Exercise | A | 0.00 | 16,667 | 0 | 16,667 | |
Jan 04 2017 | XNOM.OB | Trovagene, Inc. | Markin Rodney S | Director | Option Exercise | A | 0.00 | 16,667 | 0 | 16,667 | |
Dec 19 2016 | XNOM.OB | Trovagene, Inc. | Tennant Stanley | Director | Buy | P | 2.10 | 10,000 | 21,000 | 217,728 | 207.7 K to 217.7 K (+4.81 %) |
Dec 19 2016 | XNOM.OB | Trovagene, Inc. | WELCH WILLIAM J | CEO | Buy | P | 2.09 | 2,250 | 4,694 | 4,750 | 2.5 K to 4.8 K (+90.00 %) |
Dec 19 2016 | XNOM.OB | Trovagene, Inc. | WELCH WILLIAM J | CEO | Buy | P | 2.10 | 2,500 | 5,250 | 2,500 | 0 to 2.5 K |
Dec 19 2016 | XNOM.OB | Trovagene, Inc. | Tennant Stanley | Director | Buy | P | 2.00 | 14,966 | 29,932 | 207,728 | 192.8 K to 207.7 K (+7.76 %) |
Dec 15 2016 | XNOM.OB | Trovagene, Inc. | Erlander Mark | Chief Scientific Of ... | Buy | P | 2.08 | 5,000 | 10,375 | 5,000 | 0 to 5 K |